Systematic Literature Review of Herpes Zoster Disease Burden in Southeast Asia
ConclusionsOverall, there are limited data reporting incidence and prevalence of HZ in Southeast Asia at a national level. High rates of complications, symptoms, and abundance of case reports suggest substantial healthcare resource utilization for patients with HZ and highlight the need for further research in Southeast Asia assessing the societal impact. (Source: Infectious Diseases and Therapy)
Source: Infectious Diseases and Therapy - June 14, 2023 Category: Infectious Diseases Source Type: research
An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan
ConclusionDespite low incidence rates, VRE infections already represent a substantial economic burden to the Japanese healthcare system. The substantial increase in costs associated with a higher incidence of VRE infections could result in a significant economic challenge for Japan. (Source: Infectious Diseases and Therapy)
Source: Infectious Diseases and Therapy - June 11, 2023 Category: Infectious Diseases Source Type: research
Risks of Acute Cholecystitis, Acute Pancreatitis, and Acute Appendicitis in Patients with Dengue Fever: A Population-Based Cohort Study in Taiwan
ConclusionThis study was the first large epidemiological study to show a significantly increased risk of acute cholecystitis and pancreatitis among patients with dengue during the acute phase of dengue infection, while no such association was observed for acute appendicitis. Early identification of acute cholecystitis and pancreatitis in patients with dengue is crucial for preventing fatal complications. (Source: Infectious Diseases and Therapy)
Source: Infectious Diseases and Therapy - June 10, 2023 Category: Infectious Diseases Source Type: research
Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea
ConclusionThis active safety surveillance study confirms that QIV is well tolerated in children aged 6 –35 months in routine clinical practice in South Korea. There were no safety concerns observed in these young children. (Source: Infectious Diseases and Therapy)
Source: Infectious Diseases and Therapy - June 10, 2023 Category: Infectious Diseases Source Type: research
